Related Experiment Video

Updated: Jun 26, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

MicroRNA-dependent regulation of cKit in cutaneous melanoma

O Igoucheva1, V Alexeev

  • 1Department of Dermatology and Cutaneous Biology, Jefferson Medical College, Thomas Jefferson University, 233 S. 10th Street, Philadelphia, PA 19107, USA.

Biochemical and Biophysical Research Communications
|January 8, 2009
PubMed

Insights

Researchers discovered that microRNA-221 (miR-221) is upregulated in melanoma, directly inhibiting cKit protein expression. This finding suggests miR-221 as a potential therapeutic target for cutaneous melanoma treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Loss of cKit receptor is observed in cutaneous melanomas.
  • Previous research suggested AP2 transcription factor down-regulation as the cause.
  • This study investigates alternative mechanisms for cKit down-modulation.

Purpose of the Study:

  • To identify the mechanism of cKit receptor loss in cutaneous melanoma.
  • To explore the role of microRNAs (miRNAs) in cKit regulation.
  • To evaluate miR-221 as a potential therapeutic target.

Main Methods:

  • Analysis of 27 melanoma cell lines for AP2 and c-kit expression.
  • Genome-wide miRNA expression profiling.
  • Functional assays to assess miR-221's interaction with c-kit 3'UTR and protein inhibition.

Main Results:

  • No correlation found between AP2 and c-kit expression in melanoma cell lines.
  • Several miRNAs, notably miR-221, were found to be upregulated in melanomas.
  • miR-221 directly inhibits cKit protein translation and shows an inverse correlation with c-kit expression in melanocytic cells.
  • miR-221 was shown to inhibit cKit, p27(Kip1), and other key melanoma proteins.

Conclusions:

  • The down-modulation of cKit in melanoma occurs via a post-transcriptional mechanism involving miR-221.
  • miR-221 is a key regulator of cKit expression in melanoma.
  • miR-221 represents a potential novel therapeutic target for cutaneous melanoma.
  • Further research into upregulated miRNAs in melanoma is warranted.

More Related Videos

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model12:37

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Published on: September 7, 2013

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...